TJ Biotech Holding ApS: Financial statements 2020
CVR: 41953616
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
TJ Biotech Holding ApS (CVR 41953616) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 1,416,046 and a net result of DKK 90,196. Equity in the 2020 report amounted to DKK 23,071,464. The solvency ratio was 97.6%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,416,046
- Profit/Loss
- DKK 90,196
- Equity
- DKK 23,071,464
- Total Assets
- DKK 23,649,546
- Employees
- 1
Official annual report
How creditworthy is TJ Biotech Holding ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of December 14, 2020, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of TJ Biotech Holding ApS.
As of December 14, 2020, Thomas Engelbrecht Nordkild Jonassen is registered as director of TJ Biotech Holding ApS.
As of December 14, 2020, Thomas Engelbrecht Nordkild Jonassen is registered as an owner of TJ Biotech Holding ApS with an ownership share of 100%.
TJ Biotech Holding ApS was founded on December 14, 2020.
About TJ Biotech Holding ApS
TJ Biotech Holding ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2020. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Thomas Engelbrecht Nordkild Jonassen. The company is owned by Thomas Engelbrecht Nordkild Jonassen. The company has 1 employee (2021). In 2025, the company reported a gross profit of DKK 70,424 and a net result of DKK 4,184,576 compared with DKK 667,738 the year before. Equity in the 2025 report amounted to DKK 18,607,145.